GeneDx Holdings Corp. (WGS)

Last Closing Price: 161.95 (2025-12-04)

Common Equity (Quarterly)

Common Equity: The sum of all common equity items.

GeneDx Holdings Corp. (WGS) had Common Equity of $292.26M for the most recently reported fiscal quarter, ending 2025-09-30.

Figures for fiscal quarter ending 2025-09-30
Income Statement Financials
$116.74M
$-7.63M
$32.22M
$84.53M
$119.99M
$-3.25M
$-4.14M
$-7.39M
$-7.39M
$-7.63M
$-7.63M
$-7.63M
$-7.63M
$-3.25M
$3.22M
28.80M
28.80M
$-0.27
$-0.27
Balance Sheet Financials
$237.58M
$42.42M
$256.32M
$493.90M
$87.62M
$51.58M
$114.02M
$201.64M
Common Equity
$292.26M
$106.88M
$292.26M
28.89M
Cash Flow Statement Financials
$36.37M
$-50.45M
$24.83M
$86.20M
$96.96M
$10.76M
$22.38M
--
--
Fundamental Metrics & Ratios
2.71
--
--
0.15
0.18
72.40%
-2.78%
-2.78%
--
-6.33%
-6.54%
$21.70M
--
--
--
0.24
3.05
1.92
46.98
-2.61%
-7.14%
-1.55%
-2.22%
$10.12
$0.75
$1.26